Home > Insider Trading > Filing (0001192482-19-000424)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1561921	Tela Bio Inc.	TELA	Surgical & Medical Instruments & Apparatus (3841)	455320061

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1792303	Kurt Azarbarzin	C/O Highcape Partners Qp, L.p. 10751 Falls Road, Suite 300 Baltimore MD 21093		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-11-08	10,220	$13.00	12,675	No	4	P	Indirect	By HighCape Partners, L.P.
Common Stock	Acquisiton	2019-11-08	75,901	$13.00	260,808	No	4	P	Indirect	By HighCape Partners QP, L.P.
Common Stock	Acquisiton	2019-11-13	269	$0.00	12,944	No	4	C	Indirect	By HighCape Partners, L.P.
Common Stock	Acquisiton	2019-11-13	2,931	$0.00	15,875	No	4	C	Indirect	By HighCape Partners, L.P.
Common Stock	Acquisiton	2019-11-13	19,982	$0.00	280,790	No	4	C	Indirect	By HighCape Partners QP, L.P.
Common Stock	Acquisiton	2019-11-13	217,816	$0.00	498,606	No	4	C	Indirect	By HighCape Partners QP, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By HighCape Partners, L.P.
No	4	P	Indirect	By HighCape Partners QP, L.P.
No	4	C	Indirect	By HighCape Partners, L.P.
No	4	C	Indirect	By HighCape Partners, L.P.
No	4	C	Indirect	By HighCape Partners QP, L.P.
No	4	C	Indirect	By HighCape Partners QP, L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2019-11-13	493,357	$0.00	19,982	$0.00
Common Stock	Series A Preferred Stock	Disposition	2019-11-13	6,643	$0.00	269	$0.00
Common Stock	Series B Preferred Stock	Disposition	2019-11-13	5,377,928	$0.00	217,816	$0.00
Common Stock	Series B Preferred Stock	Disposition	2019-11-13	72,417	$0.00	2,931	$0.00
Series B Preferred Stock	Warrant (right to buy)	Disposition	2019-11-13	123,653	$0.00	123,653	$1.16
Common Stock	Warrant (right to buy)	Acquisiton	2019-11-13	123,653	$0.00	5,008	$28.65
Series B Preferred Stock	Warrant (right to buy)	Disposition	2019-11-13	1,665	$0.00	1,665	$1.16
Common Stock	Warrant (right to buy)	Acquisiton	2019-11-13	1,665	$0.00	67	$28.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect
0			No	4	C	Indirect
0			No	4	C	Indirect
0	2017-01-18	2027-01-18	No	4	C	Indirect
123,653	2017-11-13	2027-01-18	No	4	C	Indirect
0	2017-01-18	2027-01-18	No	4	C	Indirect
1,665	2019-11-13	2027-01-18	No	4	C	Indirect

Footnotes

Reflects 2,455 shares of common stock received by the reporting person as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a).
Reflects 183,907 shares of common stock received by the reporting person as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a).
Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.
Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.
Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.
Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.